System-Specific Assessments

階段 6 — 評估結果。回顧臨床、抗菌、預防和監測時間軸，並回答三個結果問題。

Trend

選擇作答後，查看答案。

Time	Data
Postoperative day 5, 0700 — Recognition	New fever, tachycardia, leukocytosis, purulent drainage, expanding erythema, and increasing tenderness trigger focused assessment, surgical notification, and evaluation for sepsis and deeper complication. A fresh dressing contains the drainage, so Standard Precautions are used with a plan to add Contact Precautions if containment fails.新發燒、心搏過速、白血球增多、膿性引流、紅斑擴大和壓痛增加，觸發了重點評估、外科通知以及敗血症和深層併發症的評估。新的敷料控制了引流，因此採用標準防護措施，並計畫在控制失敗時增加接觸防護措施。
Postoperative day 5, 0930 — Source control	The surgeon opens and drains the superficial collection and obtains an aseptic wound specimen. Blood cultures are obtained because the systemic assessment raises bacteremia concern. CT shows no leak, deep fascial process, or organ-space collection. Site- and severity-directed empiric therapy begins without avoidable delay.外科醫師打開並引流了淺層積液，並取得了無菌傷口檢體。由於全身評估引起菌血症疑慮，因此進行了血液培養。CT顯示沒有滲漏、深層筋膜病變或器官腔隙積液。針對部位和嚴重程度的經驗性治療立即開始，沒有可避免的延遲。
Postoperative day 6 — Microbiology and refinement	The wound specimen grows MRSA without a gram-negative or anaerobic pathogen; blood cultures remain negative. Broad colorectal-site empiric agents are narrowed to susceptibility-directed therapy. Route, monitoring, and duration are selected from source control, infection depth, kidney function, and clinical response.傷口檢體培養出MRSA，沒有革蘭氏陰性或厭氧病原體；血液培養結果仍為陰性。廣效結直腸部位經驗性藥物縮小為針對敏感性的治療。給藥途徑、監測和持續時間根據感染源控制、感染深度、腎功能和臨床反應選擇。
Postoperative day 7 — Clinical response	Temperature is 36.9 C, heart rate 82/min, WBC 10.9 x 10^9/L, pain 2/10, erythema has receded inside the marked border, and drainage is scant and contained. Glucose is managed by the inpatient protocol without hypoglycemia. Ordered wound care and discharge teaching continue.體溫36.9°C，心率82次/分，白血球10.9 x 10^9/L，疼痛2/10，紅斑已退縮至標記邊界內，引流稀少且已控制。血糖按照住院協議管理，沒有低血糖。醫囑的傷口護理和出院衛教持續進行。
Quality and surveillance review — Separate pathway	Infection prevention applies current NHSN criteria and the facility reporting plan. The quality team verifies prophylaxis selection and timing, discontinuation after closure, skin preparation, normothermia, and perioperative glucose below 200 mg/dL, assigning owners and remeasurement dates without naming one process variance as the cause.感染預防部門應用當前的NHSN標準和機構報告計畫。品質團隊驗證了預防性措施的選擇和時機、關閉後停用、皮膚準備、體溫正常和圍手術期血糖低於200 mg/dL，指定了負責人和重新測量日期，但沒有將某個流程差異命名為原因。

Q1. Which finding set best demonstrates that the immediate clinical response is effective?哪組發現最能證明即時臨床反應是有效的？

Blood cultures are negative, so the incision was never infected血液培養結果為陰性，因此切口從未感染 Fever and leukocytosis resolve, marked erythema recedes, pain and drainage decrease, and no deeper collection is found after source control發燒和白血球增多症狀消退，明顯紅斑減輕，疼痛和引流減少，感染源控制後未發現更深層積液 The client remains hospitalized through day 30 on unchanged broad therapy個案在第30天仍住院，接受未改變的廣效治療

Q2. Which antimicrobial interpretation is most accurate?哪種抗菌藥物解釋最準確？

Broad empiric therapy should continue because the operation involved the colon由於手術涉及結腸，應繼續廣效經驗性治療 A trough of 15 to 20 mg/L is mandatory for every superficial MRSA wound對於每個淺層MRSA傷口，谷值15至20 mg/L是強制性的 Source control, susceptibility results, infection depth, kidney function, and clinical response support narrowing and a patient-specific route, duration, and monitoring plan感染源控制、敏感性結果、感染深度、腎功能和臨床反應支持縮小治療範圍，並制定針對個案的給藥途徑、持續時間和監測計畫

Q3. Which quality and surveillance response is appropriate?哪種品質和監測反應是適當的？

Apply current NHSN criteria separately, verify prevention processes, assign improvement owners and remeasurement dates, and avoid unsupported causal attribution單獨應用當前的NHSN標準，驗證預防流程，指定改進負責人和重新測量日期，並避免無根據的因果歸因 Restart prophylactic antibiotics for all future clients until discharge對所有未來的個案重新開始預防性抗生素治療直至出院 Report every postoperative fever as an SSI without evaluating tissue level or criteria將每次術後發燒報告為手術部位感染（SSI），而不評估組織層次或標準

解析

結果評估
治療有效，因為感染源控制及時，引流液得到控制，發燒和白血球增多症狀消退，紅斑減輕，疼痛減輕，並且根據微生物學和臨床反應縮小了廣效經驗性治療範圍。陰性血液培養結果並不能排除傷口感染。預防措施審查和NHSN分類與治療分開：團隊驗證了預防性措施、皮膚準備、體溫和血糖流程，指定了負責人，並應用了當前的監測標準，但並未聲稱某個差異導致了手術部位感染（SSI）。如果嚴重MRSA感染確實需要長期靜脈注射萬古黴素，則首選AUC引導監測，而非普遍的僅谷值目標。

相同主題的下一題A nurse on a medical-surgical unit reviews the morning labs for a 67-year-old male client …本題收錄於此題庫[전통+신유형] NCLEX LEVEL UP 패키지KRW 79,000

瀏覽全部題目無需登入

用 MyMerci 全面準備 NCLEX-RN

數千道附詳細解析的 NCLEX 題型，以你的語言呈現。追蹤學習進度，讀得更聰明。

免費開始

App Store Google Play

以其他語言閱讀: English 한국어 日本語繁體中文 Tiếng Việt

僅供學習參考。實際臨床請遵循最新指引與所屬機構規範。

下一題免費開始